Patent details

EP2948183 Title: DUOCARMYCIN ADCS FOR USE IN TREATMENT OF ENDOMETRIAL CANCER

Basic Information

Publication number:
EP2948183
PCT Application Number:
PCT/EP/2015/050332
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP157002114
PCT Publication Number:
WO/2015/104373
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DUOCARMYCIN ADCS FOR USE IN TREATMENT OF ENDOMETRIAL CANCER
French Title of Invention:
CONJUGUÉS ANTICORPS-MÉDICAMENTS À BASE DE DUOCARMYCINE UTILISABLES DANS LE CADRE DU TRAITEMENT DU CANCER DE L'ENDOMETRIUM
German Title of Invention:
DUOCARMYCIN-ADCS ZUR VERWENDUNG BEI DER BEHANDLUNG VON ENDOMETRIUMKREBS
SPC Number:

Dates

Filing date:
09/01/2015
Grant date:
06/04/2016
EP Publication Date:
06/04/2016
PCT Publication Date:
16/07/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/12/2015
EP B1 Publication Date:
06/04/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/01/2017
Expiration date:
09/01/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/01/2015
 
 

Name:
Synthon Biopharmaceuticals B.V.
Address:
Microweg 22, 6545 CM Nijmegen, Netherlands (NL)

Name:
Yale University
Address:
Two Whitney Avenue, New Haven, CT 06510, United States (US)

Inventor

1

Name:
SANTIN Alessandro Davide
Address:
United States (US)

2

Name:
GOEDINGS Peter Johannes
Address:
Netherlands (NL)

Priority

Priority Number:
14150791
Priority Date:
10/01/2014
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
A61K 47/48;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages